PMID- 9488542 OWN - NLM STAT- MEDLINE DCOM- 19980402 LR - 20190831 IS - 0098-6569 (Print) IS - 0098-6569 (Linking) VI - 43 IP - 2 DP - 1998 Feb TI - Long-term results of percutaneous balloon mitral valvuloplasty for mitral stenosis: a follow-up study to 11 years in 202 patients. PG - 132-9 AB - We studied the first 202 patients with rheumatic mitral stenosis (MS) who underwent percutaneous balloon mitral valvuloplasty (PBMV) with the Inoue balloon catheter for a follow-up (FU) period of 5-11 years. Pre- and post-PBMV and at FU, the mean left atrial pressure was 21.3+/-7.4, 10.2+/-5.6, and 11.2+/-4.1 mm Hg; mean diastolic mitral gradient was 18.4+/-7.3, 2.9+/-3.2, and 5.1+/-4.3 mm Hg; and mitral valve area was 1.0+/-0.3, 2.1+/-0.6, and 1.7+/-0.5 cm2. Functional status improved from New York Heart Association (NYHA) class IV in 3, class III in 119, and class II in 80 pre-PBMV to class I in 163, class II in 37, and class III in 2 post-PBMV, and was class I in 146, class II in 39, and class III in 17 patients at FU. In the 17 patients with NYHA class III at FU, mitral restenosis was the culprit; 4 underwent repeat PBMV, 12 had mitral valve replacement for severe mitral calcification and subvalvular fusion, and 1 refused further intervention. Thus PBMV using the Inoue balloon catheter is an effective method of relieving MS with excellent long-term results in patients without severe mitral calcification and subvalvular fusion. FAU - Chen, C R AU - Chen CR AD - Department of Cardiology, Guangdong Cardiovascular Institute, Guangzhou, China. FAU - Cheng, T O AU - Cheng TO FAU - Chen, J Y AU - Chen JY FAU - Huang, Y G AU - Huang YG FAU - Huang, T AU - Huang T FAU - Zhang, B AU - Zhang B LA - eng PT - Journal Article PL - United States TA - Cathet Cardiovasc Diagn JT - Catheterization and cardiovascular diagnosis JID - 7508512 SB - IM MH - Adolescent MH - Adult MH - Aged MH - *Catheterization/adverse effects MH - Female MH - Follow-Up Studies MH - Hemodynamics MH - Humans MH - Male MH - Middle Aged MH - Mitral Valve Stenosis/etiology/physiopathology/*therapy MH - Recurrence MH - Rheumatic Heart Disease/complications MH - Treatment Outcome EDAT- 1998/03/06 03:04 MHDA- 2000/06/20 09:00 CRDT- 1998/03/06 03:04 PHST- 1998/03/06 03:04 [pubmed] PHST- 2000/06/20 09:00 [medline] PHST- 1998/03/06 03:04 [entrez] AID - 10.1002/(SICI)1097-0304(199802)43:2<132::AID-CCD5>3.0.CO;2-B [pii] AID - 10.1002/(sici)1097-0304(199802)43:2<132::aid-ccd5>3.0.co;2-b [doi] PST - ppublish SO - Cathet Cardiovasc Diagn. 1998 Feb;43(2):132-9. doi: 10.1002/(sici)1097-0304(199802)43:2<132::aid-ccd5>3.0.co;2-b.